Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged ≥3 years
- 1 August 2020
- Vol. 38 (37) , 5940-5946
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adultsVaccine, 2013
- Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in ChildrenThe Journal of Infectious Diseases, 2013
- Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adultsBMC Infectious Diseases, 2013
- A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 YearsThe Journal of Infectious Diseases, 2013
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adultsVaccine, 2013
- Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in ChildrenThe Pediatric Infectious Disease Journal, 2012
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccineVaccine, 2012
- A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adultsVaccine, 2011
- Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) modelJournal of Clinical Virology, 2011
- The need for quadrivalent vaccine against seasonal influenzaVaccine, 2010